Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$70,000.00
K-Ras oncogene interaction with Met receptor signaling in colorectal cancer
EF 2008-09
Résumé
Colorectal cancer (CRC) is the second leading cause of death from cancer. Oncogenic K-Ras mutations occur in 40-50% of CRC, 70% of which also overexpress Met, the hepatocyte growth factor receptor (HGF).
The purpose of my project is to define the Met/K-Ras - regulated signaling pathways that are needed for malignant progression in CRC. We hypothesize that downstream targets of Met and K-Ras are crucial regulators of tumour progression, and represent important prognostic markers and therapeutic targets in the treatment of CRC patients.
I will be looking for signaling mediators unique to the Met/K-Ras pathway using an approach based on protein phosphorylation. Protein phosphorylation represents one of the most important mechanisms of conducting and regulating cellular signaling. In these experiments, the DLD-1 CRC cell line (expressing overactive K-Ras), and the DKO-4 daughter cell line (expressing normal K-Ras), along with Met-overexpressing versions of both of these lines will be examined. Phosphorylated peptides from these four cell lines will be identified and quantified using high-resolution mass spectrometry and data analysis software. The information gained from this study will be used to better map the signal transduction pathways downstream of the Met/K-Ras interaction that are important in CRC progression. As well, the biological significance of novel Met phosphorylation sites or interacting proteins will be considered.
To complement this project, I am creating a parallel model system of Met/K-Ras interaction in the H460 non-small cell lung cancer (NSCLC) cell line in order to determine if any signaling mediators we find in CRC are also relevant in NSCLC.
This project has a significant chance of identifying important prognostic markers, as well as targets for developing novel targeted therapies for CRC.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
184623
Name
Organ Shawna L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
K-Ras oncogene interaction with Met receptor signaling in colorectal cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cell Biology; Colorectal Cancer; K-Ras; Met/Hgf; Molecular Biology; Phospho-Proteomics; Signal Transduction; Tyrosine Kinases
Abstract
Colorectal cancer (CRC) is the second leading cause of death from cancer. Oncogenic K-Ras mutations occur in 40-50% of CRC, 70% of which also overexpress Met, the hepatocyte growth factor receptor (HGF).
The purpose of my project is to define the Met/K-Ras - regulated signaling pathways that are needed for malignant progression in CRC. We hypothesize that downstream targets of Met and K-Ras are crucial regulators of tumour progression, and represent important prognostic markers and therapeutic targets in the treatment of CRC patients.
I will be looking for signaling mediators unique to the Met/K-Ras pathway using an approach based on protein phosphorylation. Protein phosphorylation represents one of the most important mechanisms of conducting and regulating cellular signaling. In these experiments, the DLD-1 CRC cell line (expressing overactive K-Ras), and the DKO-4 daughter cell line (expressing normal K-Ras), along with Met-overexpressing versions of both of these lines will be examined. Phosphorylated peptides from these four cell lines will be identified and quantified using high-resolution mass spectrometry and data analysis software. The information gained from this study will be used to better map the signal transduction pathways downstream of the Met/K-Ras interaction that are important in CRC progression. As well, the biological significance of novel Met phosphorylation sites or interacting proteins will be considered.
To complement this project, I am creating a parallel model system of Met/K-Ras interaction in the H460 non-small cell lung cancer (NSCLC) cell line in order to determine if any signaling mediators we find in CRC are also relevant in NSCLC.
This project has a significant chance of identifying important prognostic markers, as well as targets for developing novel targeted therapies for CRC.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Organ, Shawna L
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~